Inventor · disambiguated record
Elisabeth Souhami
Also filed as: SOUHAMI ELISABETH
4 granted patents·15 pending applications·4 citations·filing 2009–2025
67Inventor score
Top patents by PatentIndex Score
19 records- 0184US2025177487A1Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 0282US11026999B2Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2019·Granted Jun 8, 2021·1 cites·3 claims
- 0382US2025064898A1Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 0478US12186374B2Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2022·Granted Jan 7, 2025·0 cites·9 claims
- 0578US9950039B2Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2015·Granted Apr 24, 2018·2 cites·7 claims
- 0670US2022031811A1Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 0767US2021128692A1Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 0865US2011118178A1Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metforminSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Application pending·0 cites
- 0963US2019381145A1Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 1062US10434147B2Treatment type 2 diabetes mellitus patientsSANOFI AVENTIS DEUTSCHLAND·Filed 2017·Granted Oct 8, 2019·1 cites·4 claims
- 1161US2019060411A1Insulin Glargine/Lixisenatide Fixed Ratio FormulationSANOFI AVENTIS DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1258US2014371141A1Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 1356US2025269117A1Drive mechanism for an injection deviceSANOFI SA·Filed 2023·Application pending·0 cites
- 1456US2018133290A1Insulin glargine/lixisenatide fixed ratio formulationSANOFI AVENTIS DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 1555US2021093698A1Treatment of type 2 diabetes mellitusSANOFI SA·Filed 2020·Application pending·0 cites
- 1654US2025319163A1Treatment of type 2 diabetes mellitusSANOFI SA·Filed 2025·Application pending·0 cites
- 1747US2017136094A1Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metforminSANOFI AVENTIS DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 1841US2016287674A1Treatment Type 2 Diabetes Mellitus PatientsSANOFI AVENTIS DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 1931US2013296236A1Treatment protocol of diabetes type 2SILVESTRE LOUISE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elisabeth Souhami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →